Fig. 2From: Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatmentThe structure of selonsertib, a potent ASK1 inhibitor [42, 49]Back to article page